Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: IBI343 in Combination Therapy for Advanced Malignant Solid Tumors [Phase 2]
This is a Phase 2 clinical trial update for IBI343 in combination therapy targeting CLDN18.2-positive advanced solid tumors, including gastr…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification [Phase 1]
BeiGene is conducting a first-in-human Phase 1 study of BGB-53038, a pan-KRAS inhibitor, as a monotherapy or in combination, in participants…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating dual-targeting CAR-NK cells directed at mesothelin and MUC1 for advanced pancreatic ductal adenocarcin…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma [Phase 1]
First-in-human phase I/IIa trial evaluating DA 3501 in advanced gastric or gastroesophageal cancer and pancreatic ductal adenocarcinoma; cur…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors [Phase 1]
Phase 1 clinical trial update for AVA6103 in patients with locally advanced or metastatic selected solid tumors; the study is currently recr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
This entry reports a Phase 2 clinical trial of chiauranib for locally advanced or metastatic pancreatic ductal adenocarcinoma, sponsored by …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating monthly alternating cycles of nal-IRI plus 5-FU/leucovorin (NALIRIFOX) and gemcitabine plus nab-paclitaxel (GnP) as…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
ART0380 is being studied in a Phase 1/2 trial for various advanced or metastatic solid tumors and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma [Phase 1]
A Phase 1 clinical trial is evaluating the combination of radiotherapy with TTI-101 in patients with border-line resectable and locally adva…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas [Phase 1]
Phase 1 trial evaluating different doses of BI 765049 in adults with advanced colorectal cancer, gastric cancer, or pancreatic ductal adenoc…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma
Expanded access protocol for ELI-002-102 is being offered to patients with KRAS/NRAS-mutated pancreatic ductal adenocarcinoma.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update evaluating rimegepant in combination with AG chemotherapy as first-line therapy for metastatic pan…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer [Phase 1]
A Phase 1 study evaluating ASP2138 in pancreatic ductal adenocarcinoma, given before surgery and followed by chemotherapy, is currently recr…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center [NA]
An ongoing clinical trial evaluating whether physical activity and nutrition can reduce elevated pancreatic cancer risk in individuals with …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. [Phase 1]
Phase 1 clinical trial evaluating PF-07985045 alone or with other anti-cancer therapies in adults with advanced solid tumors bearing gene al…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Early Detection Initiative for Pancreatic Cancer [NA]
This entry reports a status update for an early-detection pancreatic cancer trial that is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS [Phase 1, Phase 2]
Betta Pharmaceuticals' BPI-572270 is being studied in Phase 1/2 trials for advanced solid tumors with specific RAS mutations, including non-…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
A Mayo Clinic-sponsored prospective registry for individuals at high risk of pancreatic cancer, including pancreatic ductal adenocarcinoma, …
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors [Phase 1]
A Phase 1 clinical trial from AstraZeneca evaluating a KRAS G12D-targeted TCR-T cell therapy in adults with unresectable, advanced, or metas…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update indicates that AK112 plus Cadonilimab in combination with chemotherapy is being evaluated as first-line treatment…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer [Phase 2]
This is an update on an ongoing Phase 2 clinical trial evaluating maintenance combinatorial myeloid immunotherapy for unresectable pancreati…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS [Phase 2]
Phase 2 study evaluating JYP0015 in advanced solid tumors with RAS mutations is currently recruiting, including pancreatic ductal adenocarci…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating TJ033721 (Givastomig) in adults with advanced or metastatic solid tumors; the study is currently recruiting and inc…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
This is a Phase 3 clinical trial evaluating chiauranib in combination with a PD-1 inhibitor, albumin-bound paclitaxel, and gemcitabine for m…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: How Does Pre-operative Biliary Drainage in Pancreatic Adenocarcinoma Affect Surgical Outcomes in Pancreatic Cancer Surgery
This ClinicalTrials.gov entry describes a study on whether pre-operative biliary drainage influences surgical outcomes in pancreatic ductal …